Letters to the Editor
Thanks for Fast-Acting Glucose Article
I read your December 2005 article on fast-acting glucose with some interest (“Fast-Acting Glucose: Why You Should Always Keep Some Handy,” December 2005). As a type 1 diabetic for 35 years and a pumper for 14, I always carry glucose tablets with me. I have neuropathy, and as a result, I am not always aware of the onset of hypoglycemia. My physician gave me some sage advice: Test before you get behind the wheel. That advice has kept me from driving with a low blood sugar on more than one occasion. Thank you for your magazine. My wife and I enjoy reading it every month.
Sherman Oaks, California
So Far, So Good: Reader Is Happy With Byetta
I have cut down my Glucophage dose from two tablets two times a day to one tablet a day since starting to take Byetta. Unfortunately, my weight has stayed the same—Byetta doesn’t work for emotional eating.
But I don’t feel the drop in my blood glucose in the morning—I used to have to eat again just two hours after having breakfast. To me, that is a great thing! I am pretty active, so I take Byetta with me to work and leave it in the refrigerator there. That way, if I go out after work, I can take my late afternoon/ before-dinner injection. There’s also a travel pack that has come in handy. I can take my Byetta with me if I go on long trips.
My insurance pays 80 percent of the cost, but I have to buy needles in addition to the Byetta. So I’m saving on pills but spending in other areas.
I recommend this medication to anyone. I belong to an online diabetes support group, and there are several other members who have also started on Byetta and who are very happy with it.
The side effects are not as severe as when I started on Glucophage (nausea, vomiting, diarrhea). I actually had to reduce the Glucophage dosage the second week I was on Byetta.
My endocrinologist is pleased with the results of her other patients who are taking Byetta, as well.
Is Neuropathy Relief Worth the Potential Side Effects?
I read with interest the article in your December 2005 issue (“FDA Approves Drug for Neuropathy Pain”). What really caught my eye were Lyrica’s “most common” side effects.
I want to get relief from neuropathy pain, but I may have to endure one or all of seven unpleasant side effects. So I wonder, “Why do that when I can just take a couple of Tylenol?” Taking Lyrica sounds something like making love to a porcupine—the pain would exceed the pleasure. Thank for a great magazine!
Missouri City, Texas